Evolution in the epidemiology of non-variceal upper digestive hemorrhage from 1985 to 2006;Evolución en la epidemiología de la hemorragia digestiva alta no varicosa desde el año 1985 hasta 2006

Revista Espanola de Enfermedades Digestivas

Volumn 100, Issue 5, 2008, Pages 273-277

  Jurado Hernández, Alicia María ^a,b   De Teresa Galvan J ^a   Ruiz Cabello Jimenez M ^a   Pinel Julian L M ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^b Imprenta San José ^*  (Spain)

Author keywords

Duodenal ulcer; Epidemiology; Incidence; Peptic ulcer haemorrhage

Indexed keywords

ANTICOAGULANT AGENT; ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIGESTIVE SYSTEM HEMORRHAGE; DUODENUM ULCER; ENDOSCOPY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEOPLASM; PORTAL HYPERTENSION; STOMACH ULCER; VARICOSIS;

ADULT; AGED; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 47049121785     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Boonpngmanee S, Feischer DE, Pezzullo JC, et al. The frequency of peptic ulcer as cause of upper-GI bleeding is exaggerated. Gastrointest Endosc 2004; 59: 788-94.
2. Bardou M, Toubotii YM, Benhaberou-Brun D, et al. High dose intravenous proton pump inhibition decreases both re-bleeding and mortality in high risk patients with acute peptic ulcer bleeding: A series of meta-analyses. Gastroenterology 2003; 123: A-625.
3. Leontiadis GI, Sharma VK, Howden CW. Tratamiento con inhibidores de la bomba de protones para la hemorragia aguda por úlcera péptica. Biblioteca Cochrane Plus 2006; (3).
4. American Gastroenterological Association, Wilcox CM, Allison J, Benzuly K, Borum M, Cryer B, Grosser T, et al. Consensus development conference on the use of nonsteroidal anti-inflammatory agents, including cyclooxygenase-2 enzyme inhibitors and aspirin. Clin Gastroenterol Hepatol 2006; 4: 1082-9.
5. Scheiman JM, Yeomans ND, Talley NJ, et al. Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors. Am J Gastroenterol 2006; 101: 701-10.
6. Cook DJ, Reeve BK, Guyatt GH, et al. Stress ulcer prophilaxis in critically ill patients. Resolving discordant meta-analyses. JAMA 1996; 24-31: 308-14.
7. Gisbert JP, Khorrami S, Carballo F, et al. Tratamiento de erradicación del H. pylori versus tratamiento antisecretor sin erradicación (con o sin tratamiento antisecretor de mantenimiento prolongado) para la prevención de hemorragias recurrentes por úlcera péptica (Revisión Cochrane traducida). Biblioteca Cochrane Plus 2006; (3).
8. Bardou M, Youssef M, Toubouti Y, et al. Never endoscopic therapies decrease both re-bleeding and mortality in high risk patients with acute peptic ulcer bleeding: A series of meta-analyses. Gastroenterology 2003; 123: A239.
9. Rockall TA, Logan RFA, Devlin HB, et al. Risk assessment after acute upper gastrointestinal haemorrhage. Gut 1996; 38: 316-21.
10. Vreeburg EM, Terwee CB, Snel P, et al. Validation for the Rockall scoring system in upper gastrointestinal bleeding. Gut 1999; 44: 331-5.
11. Van Leerdam ME, Vreeburg EM, Rauws EA, et al. Acute upper GI bleeding: did anything change? Time trend analysis of incidence outcome of acute upper GI bleeding between 1993/1994 and 2000. Am J Gastroenterol 2003; 98: 1494-9.
12. Longstreth GF. Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: A population-based study. Am J Gastroenterol 1995; 90: 206-9.
13. Rockall TA, Logan RFA, Devlin HB, et al. Incidence and mortality from acute upper gastrointestinal haemorrhage. BMJ 1995; 311: 222-6.
14. Barkun A, Bardou M, Marshall JK. Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med 2003; 18: 843-57.
15. British Society of Gastroenterology Endoscopy Section. Non-variceal upper gastrointestinal haemorrhage guidelines. Gut 2002; 51: 1-6.
16. Das A, Wong RC. Prediction of outcome of acute GI haemorrhage: A review of risk scores and predictive models. Gastrointest Endosc 2004; 60: 85-93.
17. Church NI, Dallal HJ, Masson J, Mowat NA. Validity of the Rockall scoring system after endoscopic therapy for bleeding peptic ulcer: A prospective cohort study. Gastrointest Endosc 2006; 63: 606-12.
18. Baradarian R, Ramdhaney S, Chapalamadugu R, et al. Early intensive resuscitation of patients with upper gastrointestinal bleeding decrease mortality. Am J Gastroenterol 2004; 99: 619-22.
19. Thomopoylus KC, Vagenas KA, Vagianos CE, et al. Changes in aetiology and clinical outcome of acute upper gastrointestinal bleeding during the last 15 years. Eur J Gastroenterol Hepatol 2004; 16: 177-82.
20. Garrido A, Márquez JL, Guerrero E, et al. Cambios en la etiología, resultados y características de los pacientes con hemorragia digestiva aguda grave a lo largo del periodo 1999-2005. Rev Esp Enferm Dig 2007; 99: 275-9.
21. Ohmann C, Imhof M, Ruppert C, et al. Time-trends in the epidemiology of peptic ulcer bleeding. Scand J Gastroenterol 2005; 40: 914-20.
22. Tenias Burillo JM, Llorente Melero MJ, Zaragoza Marcet A. Epidemilogie aspects on nonvariceal upper gastrointestinal bleeding in a Mediterranean region: Incidence an sociogeographic and temporal fluctuations. Rev Esp Enferm Dig 2001; 93: 96-105.
23. Juntabha R, Jensen DM. Management of severe upper gastrointestinal bleeding in patient with liver disease. Med Clin North Am 1996; 80: 1035-68.
24. Lanas A, Pérez-Aisa MA, Feu F, et al. A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug use. Am J Gastroenterol 2005; 100: 1685-93.
25. Marmo R, Rotondano G, Piscopo R, et al. Dual therapy versus monotherapy in the endoscopic treatment of high-risk bleeding ulcers: A meta-analysis of controlled trials. Am J Gastroenterol 2007; 102: 279-89.
26. Barkun A, Bardou M, Marshall JK. Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med 2003; 18: 843-57.
27. Barkun A, Racz I, Van Rensburg C, et al. Prevention of peptic ulcer rebleeding using continuos infusión of pantoprazole vs. ranitidine. A multicenter, multinational, randomized, double-blind, parallel-l group comparison. Gastroenterology 2004; 126: A-78.
28. Leontiadis GI, Sharma VK, Howden CW. Tratamiento con inhibidores de la bomba de protones para la hemorragia aguda por úlcera péptica. Biblioteca Cochrane Plus 2006; (3).